BLECH ISAAC 4
4 · Edge Therapeutics, Inc. · Filed Mar 18, 2019
Insider Transaction Report
Form 4
BLECH ISAAC
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-03-15−10,000→ 0 total→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2019-03-15+10,000→ 10,000 total
Footnotes (4)
- [F1]Vesting of RSUs granted to the Reporting Person on August 14, 2018.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F3]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F4]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.